PT2939665T - Composição farmacêutica para tratamento de infecções por hiv - Google Patents

Composição farmacêutica para tratamento de infecções por hiv

Info

Publication number
PT2939665T
PT2939665T PT13867546T PT13867546T PT2939665T PT 2939665 T PT2939665 T PT 2939665T PT 13867546 T PT13867546 T PT 13867546T PT 13867546 T PT13867546 T PT 13867546T PT 2939665 T PT2939665 T PT 2939665T
Authority
PT
Portugal
Prior art keywords
treatment
pharmaceutical composition
hiv infections
hiv
infections
Prior art date
Application number
PT13867546T
Other languages
English (en)
Inventor
Singkh Puniya Vikram
Andreevich Batyunin Gennady
Yurievna Malykh Natalya
Original Assignee
Otkrytoe Aktsionernoe Obschestvo Farmasyntez
Singkh Puniya Vikram
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49957619&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2939665(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Otkrytoe Aktsionernoe Obschestvo Farmasyntez, Singkh Puniya Vikram filed Critical Otkrytoe Aktsionernoe Obschestvo Farmasyntez
Publication of PT2939665T publication Critical patent/PT2939665T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
PT13867546T 2012-12-29 2013-09-19 Composição farmacêutica para tratamento de infecções por hiv PT2939665T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2012158141/15A RU2505286C1 (ru) 2012-12-29 2012-12-29 Фармацевтическая композиция для лечения вич-инфекции, способ ее получения и способ лечения

Publications (1)

Publication Number Publication Date
PT2939665T true PT2939665T (pt) 2019-06-14

Family

ID=49957619

Family Applications (1)

Application Number Title Priority Date Filing Date
PT13867546T PT2939665T (pt) 2012-12-29 2013-09-19 Composição farmacêutica para tratamento de infecções por hiv

Country Status (18)

Country Link
US (1) US10493034B2 (pt)
EP (1) EP2939665B1 (pt)
CN (1) CN104884050A (pt)
CA (1) CA2896710C (pt)
CY (1) CY1121660T1 (pt)
DK (1) DK2939665T3 (pt)
EA (1) EA029586B1 (pt)
ES (1) ES2729568T3 (pt)
HR (1) HRP20190882T1 (pt)
HU (1) HUE043694T2 (pt)
LT (1) LT2939665T (pt)
PL (1) PL2939665T3 (pt)
PT (1) PT2939665T (pt)
RS (1) RS58837B1 (pt)
RU (1) RU2505286C1 (pt)
SI (1) SI2939665T1 (pt)
TR (1) TR201908007T4 (pt)
WO (1) WO2014104929A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105194687A (zh) * 2015-10-22 2015-12-30 浙江医药高等专科学校 沙喹那韦或其甲磺酸盐的环糊精包合物制备方法
WO2017086835A1 (ru) * 2015-11-17 2017-05-26 Общество С Ограниченной Ответственностью "Валента-Интеллект" Фармацевтическая композиция, обладающая терапевтическим эффектом в отношении демиелинизирующих заболеваний (варианты)
RU2616267C1 (ru) * 2016-01-25 2017-04-13 Закрытое Акционерное Общество "БИОКОМ" Твердая лекарственная форма индинавира немедленного высвобождения и способ ее получения
CN116887866A (zh) 2020-12-03 2023-10-13 巴特尔纪念研究院 聚合物纳米颗粒和dna纳米结构组合物及用于非病毒递送的方法
WO2022216977A1 (en) 2021-04-07 2022-10-13 Batelle Memorial Institute Rapid design, build, test, and learn technologies for identifying and using non-viral carriers
WO2024085784A1 (ru) * 2022-10-19 2024-04-25 Общество С Ограниченной Ответственностью "Промомед Рус" Фармацевтическая композиция и лекарственное средство для лечения коронавирусной инфекции
WO2024091148A2 (ru) * 2022-10-26 2024-05-02 Общество С Ограниченной Ответственностью "Абицея Медикал Технолоджис" Жидкий бальнеологический концентрат и ампула с мерной шкалой и устройством для удобного дозирования бальнеологического концентрата

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
US20050048112A1 (en) * 2003-08-28 2005-03-03 Jorg Breitenbach Solid pharmaceutical dosage form
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
UY30535A1 (es) * 2006-08-10 2008-03-31 Cipla Ltd Composicion comprendiendo farmacos antirretrovirales y al menos un polimero insoluble en agua, proceso de preparacion y aplicaciones.
PA8809601A1 (es) * 2007-12-24 2009-07-23 Cipla Ltd Combinación anti-retroviral
AP2010005341A0 (en) * 2008-01-11 2010-08-31 Cipla Ltd Solid pharmaceutical dosage form
WO2010006050A1 (en) * 2008-07-09 2010-01-14 Purdue Research Foundation Hiv protease inhibitors and methods for using
EP2279728A1 (en) * 2009-07-31 2011-02-02 Ranbaxy Laboratories Limited Solid dosage forms of HIV protease inhibitors
EP2714683A4 (en) * 2011-05-27 2014-11-05 Hetero Research Foundation RITONAVIR AMORPH CO-PRECIPITATION
US20150004237A1 (en) * 2012-01-09 2015-01-01 Virginia Tech Intellectual Properties, Inc. Cellulose derivatives for inhibiting crystallization of poorly water-soluble drugs
US20150045400A1 (en) * 2012-03-01 2015-02-12 Bandi Parthasaradhi Reddy Ritonavir compositions
WO2014184553A1 (en) * 2013-05-15 2014-11-20 Cipla Limited Pharmaceutical antiretroviral compositions

Also Published As

Publication number Publication date
EP2939665B1 (en) 2019-03-20
TR201908007T4 (tr) 2019-06-21
CN104884050A (zh) 2015-09-02
HRP20190882T1 (hr) 2019-09-20
US20150297526A1 (en) 2015-10-22
US10493034B2 (en) 2019-12-03
ES2729568T3 (es) 2019-11-04
CA2896710A1 (en) 2014-07-03
WO2014104929A1 (ru) 2014-07-03
SI2939665T1 (sl) 2019-08-30
CY1121660T1 (el) 2020-07-31
RU2505286C1 (ru) 2014-01-27
PL2939665T3 (pl) 2020-01-31
LT2939665T (lt) 2019-07-25
EA029586B1 (ru) 2018-04-30
EP2939665A1 (en) 2015-11-04
HUE043694T2 (hu) 2019-09-30
EP2939665A4 (en) 2016-06-01
EA201500710A1 (ru) 2015-10-30
RS58837B1 (sr) 2019-07-31
DK2939665T3 (da) 2019-06-11
CA2896710C (en) 2019-03-26

Similar Documents

Publication Publication Date Title
HK1211589A1 (en) Compounds for the treatment of paramoxyvirus viral infections
HK1212632A1 (zh) 用於治療 介導的疾病的藥物組合物
ZA201405820B (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
PT2818482T (pt) Composição farmacêutica para o tratamento de cancro
PT2824114T (pt) Composição farmacêutica para o tratamento do cancro
SI2854768T1 (sl) Farmacevtski sestavki pemetrekseda
HK1206623A1 (en) Pharmaceutical compositions and treatment of mastitis
PT2939665T (pt) Composição farmacêutica para tratamento de infecções por hiv
HK1208378A1 (en) Pharmaceutical composition for the treatment of fungal infections
PT3524260T (pt) Composições farmacêuticas para o tratamento de inapetência
ZA201502695B (en) Stable pharmaceutical composition of peginterferon alpha-2b
HUP1200552A2 (en) Pharmaceutical compositions for the treatment of high blood pressure
PL2812351T3 (pl) Kompozycja farmaceutyczna do leczenia stwardnienia rozsianego
ZA201407866B (en) Composition for the prevention and treatment of viral infections caused by retroviruses
HUP1100245A2 (en) Pharmaceutical composition for the treatment of wounds